Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:COCH NASDAQ:PDEX NASDAQ:SMTI NASDAQ:VANI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCOCHEnvoy Medical$0.71+0.7%$0.69$0.36▼$1.89$53.82M1.9114,755 shs365,811 shsPDEXPro-Dex$66.75-0.3%$54.74$23.47▼$68.99$213.69M-0.0233,389 shs57,942 shsSMTISanara MedTech$21.26-3.0%$19.56$16.05▼$35.95$200.87M1.2147,678 shs36,466 shsVANIVivani Medical$1.30+0.8%$1.19$0.92▼$1.92$112.11M2.31200,845 shs223,291 shsThe 7 Hottest IPOs On Wall Street’s 2026 WatchlistMarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCOCHEnvoy Medical+0.71%+0.71%+3.52%+0.71%-53.00%PDEXPro-Dex-0.27%+2.46%+38.03%+38.92%+70.11%SMTISanara MedTech-3.01%-7.28%+7.75%+5.82%-26.92%VANIVivani Medical+0.78%+4.84%-4.41%+10.17%+5.69%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCOCHEnvoy Medical$0.71+0.7%$0.69$0.36▼$1.89$53.82M1.9114,755 shs365,811 shsPDEXPro-Dex$66.75-0.3%$54.74$23.47▼$68.99$213.69M-0.0233,389 shs57,942 shsSMTISanara MedTech$21.26-3.0%$19.56$16.05▼$35.95$200.87M1.2147,678 shs36,466 shsVANIVivani Medical$1.30+0.8%$1.19$0.92▼$1.92$112.11M2.31200,845 shs223,291 shsThe 7 Hottest IPOs On Wall Street’s 2026 WatchlistMarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCOCHEnvoy Medical+0.71%+0.71%+3.52%+0.71%-53.00%PDEXPro-Dex-0.27%+2.46%+38.03%+38.92%+70.11%SMTISanara MedTech-3.01%-7.28%+7.75%+5.82%-26.92%VANIVivani Medical+0.78%+4.84%-4.41%+10.17%+5.69%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCOCHEnvoy Medical 2.00Hold$2.50254.61% UpsidePDEXPro-Dex 2.33Hold$70.004.87% UpsideSMTISanara MedTech 2.00Hold$34.0059.92% UpsideVANIVivani Medical 2.00Hold$3.50169.23% UpsideCurrent Analyst Ratings BreakdownLatest COCH, VANI, SMTI, and PDEX Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/19/2026PDEXPro-Dex Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold5/12/2026PDEXPro-Dex Ascendiant Capital MarketsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$56.00 ➝ $70.005/12/2026SMTISanara MedTech Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold ➝ Strong Sell5/1/2026PDEXPro-Dex Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C+)4/24/2026COCHEnvoy Medical Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)4/21/2026SMTISanara MedTech Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)4/15/2026SMTISanara MedTech Lake Street CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$32.004/1/2026COCHEnvoy Medical Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold3/31/2026COCHEnvoy Medical HC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$2.503/31/2026VANIVivani Medical HC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$4.00 ➝ $3.50(Data available from 6/3/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCOCHEnvoy Medical$240K225.84N/AN/A($0.42) per share-1.68PDEXPro-Dex$66.59M3.20$3.13 per share21.34$11.23 per share5.94SMTISanara MedTech$103.12M1.89$0.58 per share36.87$0.67 per share31.73VANIVivani MedicalN/AN/AN/AN/A$0.20 per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCOCHEnvoy Medical-$23.76M-$1.01N/AN/AN/A-9,875.64%N/A-177.92%7/30/2026 (Estimated)PDEXPro-Dex$8.98M$3.6218.4424.01N/A16.08%22.78%14.30%7/8/2026 (Estimated)SMTISanara MedTech-$37.56M-$3.77N/AN/AN/A-31.23%-3.19%-0.56%8/12/2026 (Estimated)VANIVivani Medical-$26.61M-$0.40N/AN/AN/AN/A-264.04%-79.85%8/12/2026 (Estimated)Latest COCH, VANI, SMTI, and PDEX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/13/2026Q1 2026VANIVivani Medical-$0.08-$0.08N/A-$0.08N/AN/A5/11/2026Q1 2026COCHEnvoy Medical-$0.14-$0.11+$0.03-$0.08$0.10 million$0.04 million4/30/2026Q3 2026PDEXPro-Dex$0.62$1.20+$0.58$1.20$17.90 million$19.95 million3/26/2026Q4 2025VANIVivani Medical-$0.10-$0.09+$0.01-$0.09N/AN/A3/24/2026Q4 2025SMTISanara MedTech$0.11$0.04-$0.07-$0.19$27.90 million$27.55 million3/23/2026Q4 2025COCHEnvoy Medical-$0.24-$0.26-$0.02-$0.26$0.03 million$0.08 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthCOCHEnvoy MedicalN/AN/AN/AN/AN/APDEXPro-DexN/AN/AN/AN/AN/ASMTISanara MedTechN/AN/AN/AN/AN/AVANIVivani MedicalN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCOCHEnvoy MedicalN/A2.272.14PDEXPro-Dex0.323.672.14SMTISanara MedTech6.592.282.05VANIVivani MedicalN/A3.183.18Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCOCHEnvoy Medical8.59%PDEXPro-Dex15.28%SMTISanara MedTech8.10%VANIVivani Medical6.78%Insider OwnershipCompanyInsider OwnershipCOCHEnvoy Medical7.10%PDEXPro-Dex45.90%SMTISanara MedTech42.00%VANIVivani Medical53.30%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCOCHEnvoy Medical3476.88 million71.42 millionNot OptionablePDEXPro-Dex1403.19 million1.73 millionNot OptionableSMTISanara MedTech609.16 million5.32 millionNot OptionableVANIVivani Medical2086.24 million40.27 millionOptionableCOCH, VANI, SMTI, and PDEX HeadlinesRecent News About These CompaniesVivani Medical CEO Adam Mendelsohn to Present at the Jefferies Global Healthcare Conference on June 4, 2026May 28, 2026 | markets.businessinsider.comVivani Medical (NASDAQ:VANI) Director Buys $1,999,999.26 in StockMay 20, 2026 | insidertrades.comVivani Medical Reports First Quarter 2026 Financial Results and Provides Business UpdateMay 13, 2026 | globenewswire.comVivani Medical (VANI) to Release Quarterly Earnings on TuesdayMay 5, 2026 | marketbeat.comVivani Medical (NASDAQ:VANI) Director Gregg Williams Purchases 1,587,301 SharesApril 17, 2026 | insidertrades.comWilliams Gregg buys Vivani medical (VANI) shares worth $1.99mApril 16, 2026 | investing.comVivani Medical (VANI) Upgraded to Buy: What Does It Mean for the Stock?April 3, 2026 | zacks.comVivani Medical price target lowered to $3.50 from $4 at H.C. WainwrightApril 2, 2026 | finance.yahoo.comVivani Medical (VANI) price target increased by 10.00% to 5.61March 28, 2026 | msn.comVivani completes first-in-human study of GLP-1 implantMarch 27, 2026 | drugdeliverybusiness.comDVivani Medical, Inc. Advances NPM-139 Semaglutide Implant toward Phase 1 Clinical Study Following Successful LIBERATE-1 Trial and Positive Preclinical DataMarch 26, 2026 | quiverquant.comQVivani Medical Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business UpdateMarch 26, 2026 | globenewswire.comVivani Medical (NASDAQ:VANI) Director Buys $1,685,497.17 in StockMarch 17, 2026 | insidertrades.comVivani medical director Williams buys shares worth $1.68 millionMarch 16, 2026 | investing.comVivani Medical Introduces Long-Acting Implant for GLP-1 MedicationsMarch 3, 2026 | mddionline.comMWilliams Gregg buys Vivani medical (VANI) shares worth $1.98 millionFebruary 17, 2026 | investing.comCortigent reports positive 6-year findings for brain implant for providing artificial visionJanuary 29, 2026 | massdevice.comVivani Subsidiary Cortigent Presents Promising 6-Year Early Feasibility Study Results for the Orion System at NANS 2026January 29, 2026 | globenewswire.comVivani Medical (NASDAQ:VANI) Director Gregg Williams Buys 1,351,351 SharesJanuary 29, 2026 | insidertrades.comWilliams Gregg buys Vivani Medical (VANI) shares for $1.99mJanuary 28, 2026 | investing.comVivani Medical, Inc. Closes $4.5 Million Direct Offering and Private Placement to Support Clinical DevelopmentJanuary 27, 2026 | quiverquant.comQNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCOCH, VANI, SMTI, and PDEX Company DescriptionsEnvoy Medical NASDAQ:COCH$0.70 +0.01 (+0.71%) Closing price 06/2/2026 04:00 PM EasternExtended Trading$0.69 -0.02 (-2.55%) As of 09:26 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.Pro-Dex NASDAQ:PDEX$66.75 -0.18 (-0.27%) Closing price 06/2/2026 04:00 PM EasternExtended Trading$66.75 0.00 (0.00%) As of 07:59 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company's products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California.Sanara MedTech NASDAQ:SMTI$21.26 -0.66 (-3.01%) Closing price 06/2/2026 04:00 PM EasternExtended Trading$21.09 -0.17 (-0.78%) As of 04:19 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Sanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical, wound, and skincare products and services to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical, a medical hydrolysate of Type I bovine collagen indicated for the management of surgical, traumatic, and partial- and full-thickness wounds, as well as first- and second-degree burns; and HYCOL, a medical hydrolysate of Type I bovine collagen intended for the management of full and partial thickness wounds, including pressure ulcers, venous and arterial leg ulcers, and diabetic foot ulcers. It also provides BIAKOS Antimicrobial Skin and Wound Cleanser, a patented product that contains synergistic ingredients that have been shown to impact mature biofilm microbes; BIAKOS Antimicrobial Wound Gel, an antimicrobial hydrogel wound dressing that helps against planktonic microbes, as well as immature and mature biofilms; and BIAKOS Antimicrobial Skin and Wound Irrigation Solution. In addition, it develops BIASURGE, a no-rinse surgical solution used for wound irrigation; FORTIFY TRG, a freeze-dried, multi-layer small intestinal submucosa extracellular matrix sheet; FORTIFY FLOWABLE extracellular matrix, an advanced wound care device; TEXAGEN, a multi-layer amniotic membrane allograft used as an anatomical barrier with robust handling that can be sutured for securement; and VIM Amnion Matrix, a homologous wound covering product. Sanara MedTech Inc. was incorporated in 2001 and is based in Fort Worth, Texas.Vivani Medical NASDAQ:VANI$1.30 +0.01 (+0.78%) Closing price 06/2/2026 04:00 PM EasternExtended Trading$1.30 0.00 (0.00%) As of 09:17 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Marvell Stock Soars on NVIDIA's Trillion-Dollar Nod Dollar General Signals Reversal With 60% Rebound Potential Kohl's Stock Soars After Better-Than-Feared Quarter Credo Technologies Paved a Path to a $300 Price Point MGM Buyout: The House Doesn't Always Win Alphabet's $80 Billion Offering: Worrisome Dilution or AI Confidence? FirstCash Turns Pawn Into a Growth Machine HubSpot Just Crushed the Bear Case—Is a Bigger Rally Ahead? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
